Suminguit, Leonor G.
HRN: 28-82-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFTAZIDIME 1GM (VIAL)
09/29/2023
10/05/2023
IV
1gram
Q8hrs
CAP-MR; T/C PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes